Case report: Pembrolizumab as an alternative to atezolizumab following a severe infusion reaction: The emergence of immune-checkpoint inhibitors (ICIs) has revolutionized the field of oncology, providing promising results in… … #oncology https://t.co/yiVmA
18,959 followers
12,118 followers
RT @FrontOncology: New research: Case report: Pembrolizumab as an alternative to atezolizumab following a severe infusion reaction: The eme…
6,544 followers
New research: Case report: Pembrolizumab as an alternative to atezolizumab following a severe infusion reaction: The emergence of immune-checkpoint inhibitors (ICIs) has revolutionized the field of oncology, providing promising results in… https://t.co/Mmz